Manufacturing

Suzanne Shelley is a contributing editor to 

Articles

Cold chain stakeholders continue to innovate with new technology development, the use of advanced modeling and analytics capabilities, and the pursuit of strategic partnerships.

Protecting Biologics at Every Turn

The new policy will require trading partners to supply, accept, and manage all documentation of product and ownership of prescription drugs electronically.

FDA Establishes Stabilization Period for Updated DSCSA Compliance Policies

Feliza Mirasol is the science editor for 

Under the exclusive agreement, Hikma will commercialize products in Rakuten Medical’s pipeline for cancer treatment in the Middle East and North Africa region.

Rakuten Medical Signs Exclusive Licensing Agreement with Hikma for Cancer Treatments in MENA

Mike Hennessy Jr. is the President and CEO of 

A proposed database includes key information about critical drugs, such as the country of origin and quantity, so supply chain weaknesses can be identified. 

Supply Chain Securities

The damage to the facility, which produces 8% of US injectable drug consumption, should not significantly affect the current supply.

Update on Storm Damage to Pfizer Facility in North Carolina

Cold chain stakeholders continue to innovate with new technology development, the use of advanced modeling and analytics capabilities, and the pursuit of strategic partnerships. 

Protecting High-value Biologics at Every Turn

 Washington Editor, jillwechsler7@gmail.com.

Problems continue despite actions by regulators to better prevent and address drug shortages.

Drug Shortages Continue to Plague FDA and Manufacturers

Chris Spivey is the editorial director of 

Vaccine nationalism strengthens viruses and poses deadly risks for all involved.

Vaccine Nationalism Escalating Risk

Jane True, vice-president of mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead, Pfizer, shares her perspective on how mRNA will shift commercial models in the pharmaceutical industry.

How mRNA will Shift Pharma Commercial Models with Jane True, Pfizer

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

The event, cosponsored by FDA and USP, hosted regulators and industry leaders to discuss the challenges in strengthening the medical product supply chain.

Supply Chain/Logistics